| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8222548 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 8 Pages |
Abstract
After SRT, a short IBF can be used for early identification of patients who are most likely to experience progression to DM, PCSM, and OM. IBF â¤18 months may be useful in clinical practice or as an endpoint for clinical trials.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Skyler BS, William BS, Darren BS, Yeohan BS, Corey BS, Ben BS, Jessica MD, Jeffrey MD, Felix MD, Daniel MD, PhD,